Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)
NCT ID: NCT07200414
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
14768 participants
INTERVENTIONAL
2024-10-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does offering an integrated package of adolescent health services increase the proportion of 9-year-old girls who receive the HPV vaccine?
Does this package increase use of other services such as reproductive health counseling, nutrition and vision screening, mental health services, and deworming among girls and boys ages 9-15 years?
Researchers will compare areas that receive the integrated package to areas that continue with the standard government services to see if the intervention improves vaccination and health service use.
Participants will:
Be surveyed about HPV vaccination and health service use before and after the program is offered.
Take part in interviews or focus groups about experiences with adolescent health services.
Be offered HPV vaccination and other adolescent health services through local health facilities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated HPV Vaccination and Adolescent Health in Ivory Coast
NCT06997705
HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial
NCT03832049
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697
Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
NCT00120848
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
NCT00092547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention will leverage the routine government health system to deliver an integrated package of adolescent health services that includes HPV vaccination and additional services such as sexual and reproductive health counseling, general health check-ups, nutrition and vision screening, mental health services, deworming, and dental and oral health care.
The primary objective is to determine the effect of the integrated package on HPV vaccine coverage among 9-year-old girls. Secondary objectives include: (1) assessing changes in uptake of other adolescent health services among girls and boys aged 9-15 years, (2) examining feasibility, acceptability, and fidelity of the intervention from the perspective of adolescents, parents, providers, and policymakers, and (3) estimating incremental costs of delivering the integrated package.
The study design includes three phases: formative research, implementation, and evaluation. Baseline and endline household surveys will be conducted with parents and adolescents, supplemented by qualitative data collection (in-depth interviews (IDI), focus groups, key informant interviews (KII), and multi-informant interviews (MII)). Service delivery records and costing data from 30 health facilities will also be analyzed.
Comparison will be made between intervention and comparison local government areas to assess differences in HPV vaccine uptake and adolescent health service utilization. The study will generate evidence on strategies to improve HPV vaccination coverage and strengthen adolescent health service delivery in Nigeria.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Adolescent Health Package
Local government areas (LGAs) where the routine government health system delivers an integrated package of adolescent health services. The package includes HPV vaccination, sexual and reproductive health counseling, general health check-ups, nutrition and vision screening, mental health support, deworming, and dental and oral health services.
Integrated Adolescent Health Package
Delivery of an integrated package of adolescent health services through government health facilities. The package includes HPV vaccination, sexual and reproductive health counseling, general health check-ups, nutrition and vision screening, mental health support, deworming, and dental and oral health services. Implemented in intervention LGAs in Lagos and Kebbi States.
Standard Services
Local government areas (LGAs) where only standard government health services are provided. HPV vaccination and other adolescent health services are delivered according to routine practice without the additional integrated package.
Routine Government Health Services
Routine government health services provided in comparison LGAs. Services may include HPV vaccination as per national immunization schedules and other adolescent health services delivered under existing programs, but without the integrated package.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated Adolescent Health Package
Delivery of an integrated package of adolescent health services through government health facilities. The package includes HPV vaccination, sexual and reproductive health counseling, general health check-ups, nutrition and vision screening, mental health support, deworming, and dental and oral health services. Implemented in intervention LGAs in Lagos and Kebbi States.
Routine Government Health Services
Routine government health services provided in comparison LGAs. Services may include HPV vaccination as per national immunization schedules and other adolescent health services delivered under existing programs, but without the integrated package.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least one year of experience in current position
* Be part of the HPV vaccine working group and be engaged in discussions around the HPV routinization plan.
* Be involved in the Routine Immunization (RI) working group at the national or state level, or be part of the local government (LG) RI team, and participate in regular discussions about the HPV vaccination program
* Have been involved in the HPV vaccine rollout, including planning, training, deployment, fieldwork, or assessment activities.
* Must be knowledgeable about vaccination programs in the country and able to provide valuable insights into service delivery practices at different levels.
Program managers from the Ministries of Health, and Education must:
* Have at least one year of experience in current position
* Be knowledgeable about adolescent health programs or policies as it relates to the Ministry and its engagements with Ministry of Health and NPHCDA
Health service providers must:
* Have at least one year of experience in current position
* Provide immunization services at the facility, school or community levels
* Have been involved in the HPV vaccine rollout, including planning, training, deployment, fieldwork, or assessment activities.
* Must be knowledgeable about vaccination programs in the country and able to provide valuable insights into service delivery practices at different levels.
School-based service providers such as principals, teachers and school nurses must:
* Have at least one year of experience in current or similar roles within the educational system.
* Have previous involvement or interest in school health initiatives, adolescent health issues, including sexual health education, vaccination programs etc.
* Be employed in schools located within Lagos or Kebbi states where adolescent girls (9-15 years) attend
* Be a representative from public, private, urban or rural schools, including those serving underprivileged students.
* Be willing to participate in interviews and share experiences and opinions.
* Be proficient in English or Yoruba for Lagos, or English or Hausa for Kebbi
Civil Society Organization (CSO) partner in the state must:
* Be engaged in any of the following cervical cancer elimination, HPV vaccination, girl-child education, internally displaced persons rehabilitation, and youth empowerment within the last 2 years in the intervention LGAs
* Have working relationship with the immunization program at the national, state, local or ward level
Adolescent male and female respondents:
* Must be aged between 9-19 years for the HCD workshop, (In-Depth Interview) IDIs and FGDs, and aged between 9-15 years for the household surveys
* Must reside in the study states (Lagos or Kebbi and in the study LGAs) to be considered for all data collection activities,
* Must have parental or guardian consent to participate in all data collection activities unless classified as emancipated minors.
* In addition to having parental or guardian consent, adolescents must be willing to participate in the data collection activities.
* Adolescents aged 9 to 17, who are legally considered emancipated (e.g. married) can provide consent for participation in all data collection activities without requiring parental or guardian consent
* Must not have participated in any other data collection activity in the study, since distinct adolescents will be enrolled for each data collection activity.
Parents must:
* Be parents or legal guardians of adolescents aged 9-19 years.
* Reside in Lagos or Kebbi states.
* Be willing to participate in the interview process and share experiences, concerns, and suggestions.
* Be proficient in English or Yoruba for Lagos, or English or Hausa for Kebbi.
Community leaders:
* Have at least one year of experience in current role
* Reside in Lagos or Kebbi states
* Must be residing in the community for more than 1 year
* Be willing to participate in the interview process and share experiences, concerns, and suggestions.
* Be proficient in English or Yoruba for Lagos, or English or Hausa for Kebbi.
Exclusion Criteria
* Individuals unable to participate due to time constraints or conflicting responsibilities.
* Those not proficient in the necessary languages (English or Yoruba for Lagos, English or Hausa for Kebbi).
* For the Key Informant Interviews (KIIs), Multi-Informant Interviews (MIIs), Focus Group Discussions (FGDs) and Household Surveys (HHS): sub-national level individuals not residing in the respective study states (Lagos and Kebbi)
* For the Human-Centered Design Workshop (HCD) workshop: LGA, ward, facility, community, school-level participants who are not from the intervention LGA
* Those who do not provide consent or assent.
* Those who lack the capacity to provide consent or assent or participate effectively
2. For specific participant types
* Immunization program managers from NPHCDA, state and LGA levels
* Individuals with less than one year experience in current position and in immunization programs.
* Those who have not been involved in HPV vaccination program operations or lack a comprehensive view of potential service delivery options.
* Program managers who do not belong to the National or state or LGA or Ward HPV Technical Working Group
* Program managers from the Ministry of Health, Women affairs and Education
* Individuals with less than one year experience in current position.
Health service providers:
* Healthcare workers who didn't participate in the HPV vaccine introduction and has less than 1 year working in routine immunization.
* School-based service providers such as principals, teachers and school nurses
* Individuals without experience teaching adolescents 9-15 years or lacking familiarity with the educational system.
* Teachers or principals from institutions not relevant to the study, such as boys-only school, or universities.
Adolescents:
* Adolescents outside the specified age range of 9-19 years.
* Those unable to communicate effectively, even with interpreters or accommodation.
* Adolescents with medical conditions preventing participation in discussions about vaccination or health.
* Those whose parents or guardians do not provide consent or who do not assent to participate.
* Wards of the state or adolescent under government supervision
Parents:
* Individuals who are not parents or guardians of adolescents aged 9-15 years.
* Parents with extreme beliefs or conspiracy theories about vaccinations that may not contribute constructively to the program design process (For HCD only)
* School teachers in only boys' school or girls outside the age range of 9-15 years.
* Community influencers that have resided in the community for less than one year
9 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direct Consulting and Logistics
UNKNOWN
Jhpiego
OTHER
Gavi, The Vaccine Alliance
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chizoba Wonodi, MBBS, DrPH, MPH
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lagos State Ministry of Health/Kebbi State Ministry of Health
Lagos, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Adeyanju GC, Essoh TA, Sidibe AR, Kyesi F, Aina M. Human Papillomavirus Vaccination Acceleration and Introduction in Sub-Saharan Africa: A Multi-Country Cohort Analysis. Vaccines (Basel). 2024 May 1;12(5):489. doi: 10.3390/vaccines12050489.
Lawson O, Ameyan L, Tukur Z, Dunu S, Kerry M, Okuyemi OO, Yusuf Z, Fasawe O, Wiwa O, Hebert KS, Joseph JT, Nwokwu UE, Okpako O, Chime CI. Cervical cancer screening outcomes in public health facilities in three states in Nigeria. BMC Public Health. 2023 Sep 1;23(1):1688. doi: 10.1186/s12889-023-16539-1.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00030748
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.